HHS Awards $90 Million to Support Health Centers in Addressing Hypertension Among Racial and Ethnic Minorities

The Health Resources and Services Administration (HRSA) awarded nearly $90 million in funding to 496 health centers across 48 states, the District of Columbia, Federated States of Micronesia, Puerto Rico, Palau, and the U.S. Virgin Islands. Funding aims to address hypertension, improve heart health, and reduce disparities in COVID-19 outcomes among racial and ethnic minority communities.
Source: News stories via the Rural Assistance Center - Category: Rural Health Source Type: news

Related Links:

This study compared approximately 390,000 people who received the Company’s single-shot COVID-19 vaccine versus approximately 1.52 million unvaccinated people matched on age, sex, time, three-digit zip code, and comorbidities and predictors for COVID-19 infection severity.This study is a longitudinal cohort design, using robust propensity matching methods to create a comparator cohort to assess real-world VE. All analyses were performed using the Aetion Evidence Platform, which is a scientifically validated software that is also used by regulators, payers, and health technology assessment bodies to assess the safety,...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Int Heart J. 2021 Sep 17. doi: 10.1536/ihj.21-069. Online ahead of print.ABSTRACTThere is emerging evidence of prolonged recovery in survivors of coronavirus disease 2019 (COVID-19), even in those with mild COVID-19. In this paper, we report a case of a 39-year-old male with excessive body weight and a history of borderline values of arterial hypertension without therapy, who was mainly complaining of progressive dyspnea after being diagnosed with mild COVID-19. According to the recent guidelines on the holistic assessment and management of patients who had COVID-19, all preferred diagnostic procedures, including multidete...
Source: International Heart Journal - Category: Cardiology Authors: Source Type: research
AbstractCoronavirus disease 2019 (COVID-19) accounts for over 180,000 deaths in the USA. Although COVID-19 affects all racial ethnicities, non-Hispanic Blacks have the highest mortality rates. Evidence continues to emerge, linking the disproportion of contagion and mortality from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a result of adverse social determinants of health. Yet, genetic predisposition may also play a credible role in disease transmission. SARS-CoV-2 enters cells by interaction between SARS-CoV-2 spike protein and the receptor molecule angiotensin converting enzyme 2 (ACE2) expressed on the...
Source: Journal of Racial and Ethnic Health Disparities - Category: International Medicine & Public Health Source Type: research
In conclusion, the study highlights that the effect of public restrictions to mitigate the COVID-19 pandemic on essential care systems should be considered.PMID:34544048 | DOI:10.4269/ajtmh.21-0354
Source: Am J Trop Med Hyg - Category: Infectious Diseases Authors: Source Type: research
CONCLUSIONS: in the present study, nutritional status (SGA) and NRS 2002 were major mortality risk factors for CODIV-19 patients in the ICU.PMID:34538061 | DOI:10.20960/nh.03749
Source: Nutricion Hospitalaria - Category: Nutrition Authors: Source Type: research
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Am J Manag Care. 2021 Sep;27(9):366-368. doi: 10.37765/ajmc.2021.88644.ABSTRACTAmong a group of primary care accountable care organizations, patients with hypertension were 50% less likely to have a blood pressure recorded in April compared with February.PMID:34533905 | DOI:10.37765/ajmc.2021.88644
Source: The American Journal of Managed Care - Category: Health Management Authors: Source Type: research
AbstractAimsWe assessed the outcome of hospitalized coronavirus disease 2019 (COVID-19) patients with heart failure (HF) compared with patients with other cardiovascular disease and/or risk factors (arterial hypertension, diabetes, or dyslipidaemia). We further wanted to determine the incidence of HF events and its consequences in these patient populations.Methods and resultsInternational retrospective Postgraduate Course in Heart Failure registry for patients hospitalized with COVID-19 and CArdioVascular disease and/or risk factors (arterial hypertension, diabetes, or dyslipidaemia) was performed in 28 centres from 15 cou...
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Original Research Article Source Type: research
Eur Respir Rev. 2021 Sep 15;30(161):210059. doi: 10.1183/16000617.0059-2021. Print 2021 Sep 30.ABSTRACTAcute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, such as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ARDS is characterised by diffuse alveolar damage that leads to protein-rich pulmonary oedema, local alveolar hypoventilation and atelectasis. Inadequate perfusion of these areas is the main cause of hypoxaemia in ARDS. High perfusion in relation to ventilation (V/Q
Source: Respiratory Care - Category: Respiratory Medicine Authors: Source Type: research
We report a COVID-19 case with acute heart and kidney failure in a healthy young male. Echocardiography showed severe systolic and diastolic left ventricle dysfunction, with diffuse myocardial thickening. Cardiac MRI showed aspects of focal myocarditis, and hypertensive cardiomyopathy. Renal biopsy demonstrated limited acute tubular injury, and hypertensive kidney disease. Coronary angiography excluded critical stenoses. Unlike what we initially suspected, myocardial inflammation had a limited extent in our patient; severe hypertension causing cardiomyopathy and multi-organ damage, not diagnosed before, was primarily respo...
Source: Monaldi Archives for Chest Disease - Category: Respiratory Medicine Authors: Source Type: research
More News: Cardiology | COVID-19 | Funding | Heart | Hypertension | Micronesia Health | Palau Health | Rural Health